Alpha-1 Antitrypsin Deficiency is a genetic disorder that can result in serious lung disease. This not-so-rare genetic disease is greatly underdiagnosed and is the most common known genetic risk factor for emphysema. Up to 3% of all people diagnosed with COPD may have undetected Alpha-1 Antitrypsin Deficiency. This presentation will provide the respiratory therapist with an appreciation of the disease, its prevalence, and its role in COPD as well as strategies for the respiratory therapist to assist in detection, education, and treatment of this population.
Presented by Robert Sandhaus MD, PhD, FCCP
Original webcast date: July 10, 2018
This archived webcast is approved for 1.0 CRCE Hour
**Please note that all programs require the participant to view the entire program prior to taking the final quiz and obtaining a course certificate.**
- Identify the prevalence of Alpha-1 Antitrypsin Deficiency
- Explain the potential roles of the respiratory therapist in detection and testing for Alpha-1 Antitrypsin Deficiency
- Evaluate the ways that a respiratory therapist can educate and help individuals with Alpha-1 Antitrypsin Deficiency live successfully and with improved quality of life